Navigation Links
Socioeconomic status plays major role in opioid pain control
Date:6/26/2013

Patients in moderate to severe pain in emergency rooms across the U.S. are less likely to receive opioid pain medications if they are black, Hispanic, poor, or have less education, compared to more affluent patients, according to a University of Rochester Medical Center study reported in the Journal of General Internal Medicine.

The study took place against the backdrop of a national epidemic of narcotics abuse, combined with a need to satisfy patients' legitimate complaints of pain.

Racial and ethnic disparities are already well-documented in the scientific literature, but the URMC team believes they are the first to investigate whether aspects of socioeconomic status -- poverty, income and education levels -- also influence the prescription of opioid pain medications.

The results point to a need for a national discussion to increase awareness and to provide consistent and unbiased treatments, said corresponding author Robert J. Fortuna, M.D., assistant professor of Medicine and Pediatrics and member of the Center for Primary Care, with a special research interest in improving health care delivery.

Investigators analyzed a cross-section of data from the National Hospital Ambulatory Care Survey of people 18 and older from 2006 to 2009, which showed that more than 50,000 visits took place at approximately 1,400 emergency departments at which opioids were prescribed. They used zip codes to identify socioeconomic status.

(Medications that fall within the opioid class include hydrocodone, e.g., Vicodin; oxycodone, e.g., OxyContin, Percocet; morphine, e.g., Kadian, Avinza; codeine, and related drugs.)

Results confirmed that people of black race or Hispanic ethnicity were less likely to get opioids for equivalent levels of pain. Similarly, people who resided in poorer neighborhoods were less likely to be treated with opioids than those from more affluent areas. For example, patients in the highest income neighborhoods received prescriptions 49 percent of the time for moderate to severe pain, versus 39 percent of the time for patients from lower income areas. Discrepancies also existed among various levels of poverty, with the poorest least likely to get opioids for pain. (Prior studies have documented similar outcomes based on race, even in cases where a patient has a bone fracture.)

Regional differences also were observed, with opioids prescribed more often at emergency departments in the South and West, compared to the Northeast. Although the study was not designed to answer why the disparities occur, the authors said the reasons are complex and should be investigated further. Co-authors Michael Joynt, M.D., and Meghan Train, D.O., a resident in the Department of Medicine at URMC, said that uniform standards and more medical education would help to promote unbiased prescribing.


'/>"/>

Contact: Leslie Orr
leslie_orr@urmc.rochester.edu
University of Rochester Medical Center
Source:Eurekalert

Related medicine news :

1. US health disadvantage spans age and socioeconomic groups
2. Socioeconomic status linked to childhood peanut allergy
3. Ethnic disparities in breast cancer survival remain despite socioeconomic similarities
4. Socioeconomic disadvantage linked to breast cancer tumor disparity
5. Study finds socioeconomic status linked to weight gain and risk of obesity in African-American women
6. Hospital readmission rates linked to availability of care, socioeconomics
7. Actos Lawsuits Move Forward, as Bernstein Liebhard LLP Reports on Recent Status Conference in Federal Actos Bladder Cancer Litigation
8. Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation
9. Whooping cough can be deadly for infants, but 61 percent of adults dont know their vaccine status
10. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Pradaxa Side Effects Litigation
11. Smart ERP Solutions Achieves Oracle Exadata Ready and Oracle Exalogic Ready Status
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... ... Reltok Nasal Products proudly announces that Boston Medical Products, Inc., a leading ... specialty, has added the KOTLER NASAL AIRWAY™ to its diverse product line. , A ... safety device secured by nasal surgeons onto the floor of the nasal passages, at ...
(Date:4/29/2016)... ... April 29, 2016 , ... Jvion, the market leader ... led by Eastside Partners, with participation from existing investor Martin Ventures. The ... accelerate its technology and product roadmap. , “Jvion is experiencing significant ...
(Date:4/29/2016)... ... April 29, 2016 , ... Regenerative Medicine Solutions (RMS) scored ... satisfaction survey, earning them second place for Tampa’s Best Places to Work. They were ... “This is a great accomplishment for our team,” says RMS Human Resources Manager Irene ...
(Date:4/29/2016)... ... April 29, 2016 , ... The infertility specialists at HRC Fertility/Orange County (HRC/OC) ... Daniel A. Potter -- are proud of the recent release of their 2014 in ... SART published the latest verified data for 375 U.S. member clinics. *Preliminary ...
(Date:4/29/2016)... ... April 29, 2016 , ... Natren, Inc. ... line of probiotics, Petbiotics ™, as they fondly call them. As animal ... groups networking for their non-profit organizations. Animal rescues across the nation face huge ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... 29, 2016 Acquisition Expands ... Product Development Capabilities in North America ... . Indegene ( http://www.indegene.com ), ... acquisition of Skura Corporation,s life science business. Skura,s ... sales enablement technology for life science organizations and ...
(Date:4/29/2016)... 29, 2016 ... Sanofi, leader mondial et ... résultats pour le premier trimestre 2016. ... Contamine, commente les résultats du premier ... pour le reste de l,année. ...
(Date:4/29/2016)... Glycotope GmbH, a clinical-stage immuno-oncology company built ... Dr. Alfredo Zurlo as Chief Medical Officer. ... years clinical experience and a proven track record in ... at Mologen AG where he was Chief Medical Officer ... held various positions at F Hoffmann La Roche and ...
Breaking Medicine Technology: